Webinars

Each month, ALS TDI brings together researchers from our lab and others for a conversation about an important topic to patients today. These can be on a specific trial, an emerging technology, or a broad theory gaining notoriety in the effort to combat ALS. These conversations are designed to ask these researchers direct questions and to provide a place where YOU and YOUR family can speak directly to those working on your behalf at ALS TDI and other labs. These webinars are recorded, but we encourage folks to join us live as your questions and interaction with these researchers is incredibly important.

Our Latest - ALS Unfiltered 2018 Webinar: Important & Currently Enrolling ALS Clinical Trials

The goal of our webinars is to provide direct answers to people with ALS, their families and others involved or interested in research leading to the development of effective treatments and cures for ALS.

This session will review the three Phase 3 trials enrolling people with ALS in the US/EU right now: NurOwn, levosimendan, and arimoclomol as well as major Phase 2 trials, such as reldesemtiv.

Previous Webinars

ALS Unfiltered 2018 Webinar: Important & Currently Enrolling ALS Clinical Trials (September 25, 2018)

WATCH

Midyear ALS Research Review (June 13, 2018)

WATCH

Research Update from Steve Perrin, Ph.D. (CEO/CSO of ALS TDI) (May 16, 2018)

WATCH

How do drugs get approved by the FDA? (March 8, 2018)

WATCH

Top 10 Things to Look for in ALS Research in 2018 (January 24, 2018)

WATCH

Recap of International ALS/MND Research Symposium (December 14, 2017)

WATCH

Looking for a way to join us in the fight to end ALS?

There are over 300 events that together raised $100 million to support our mission. Will you help?

Host an event View all events Host an event View all events

View Event Calendar

Favorable Mentions

I am committed to give all I can because I know the people at TDI are commited to give all they can as we research for treatments and a cure.

Rev Bill Hassel Victoria, TX

ALS TDI undoubtedly sets themselves apart. It's a nimble organization that can react quickly to research opportunities, provide donor confidence through transparency and keeps their main focus on treatments. With their hallways filled with photos of ALS fighters from yesterday and today... I felt like this organization has their eyes on the prize, speed to a cure.

Trickett Wendler

ALS TDI puts a face on ALS research. I'm sure there is other good research being done, but it's not as accessible as ALS TDI. It means a lot to know they actively make sure the ALS community is central to their work.

Steve Saling